-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AVKBgJmZRTd4SaYTMBMKw+SDwn8Zutr2PGzb54N8Lxl4rOa8nch6XtxaOhyP5Qf/ bBynrJ5SKwawgky1zeK7JQ== 0001231977-07-000033.txt : 20070601 0001231977-07-000033.hdr.sgml : 20070601 20070601163036 ACCESSION NUMBER: 0001231977-07-000033 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070601 FILED AS OF DATE: 20070601 DATE AS OF CHANGE: 20070601 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000899866 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133648318 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 BUSINESS PHONE: 2037761790 MAIL ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SQUINTO STEPHEN P CENTRAL INDEX KEY: 0001231954 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27756 FILM NUMBER: 07894579 MAIL ADDRESS: STREET 1: C/O ALEXION PHARMACEUTICALS INC STREET 2: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06410 4 1 primary_doc.xml PRIMARY DOCUMENT X0202 4 2007-06-01 0 0000899866 ALEXION PHARMACEUTICALS INC ALXN 0001231954 SQUINTO STEPHEN P C/O ALEXION PHARMACEUTICALS INC 352 KNOTTER DRIVE CHESHIRE CT 06410 0 1 0 0 EVP & Head of Research Common Stock, par value $.0001 per share 2007-06-01 4 M 0 16250 9 A 41264 D Common Stock, par value $.0001 per share 2007-06-01 4 M 0 8750 9.5 A 50014 D Common Stock, par value $.0001 per share 2007-06-01 4 S 0 25000 48.5 D 25014 D Option to Purchase Common Stock 9 2007-06-01 4 M 0 16250 0 D 1998-12-04 2008-12-04 Common Stock, par value $.0001 per share 16250 8750 D Option to Purchase Common Stock 9.5 2007-06-01 4 M 0 8750 0 D 1999-07-27 2009-07-27 Common Stock, par value $.0001 per share 8750 0 D The sales reported by this Form 4 are made pursuant to the terms of a Sales Plan designed to meet the requirements of Rule 10b5-1 (c) (1) of the Securities Exchange Act. /s/ Stephen Squinto 2007-06-01 -----END PRIVACY-ENHANCED MESSAGE-----